Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 20/20 | 0.81 |
| ▸ | PIM3 | Q86V86 | 20/20 | 0.81 |
| ▸ | PIM2 | Q9P1W9 | 20/20 | 0.81 |
| ▸ | GSK3B | P49841 | 1/20 | 0.70 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.70 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.70 |
| ▸ | PKN1 | Q16512 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17115552 | 1.00 | PIM1 (0.81) | PIM1PIM3PIM2GSK3BPRKCQ | |
| SCHEMBL9608821 | 0.90 | PIM1 (1.00) | PIM1PIM3PIM2GSK3BPRKCQ | |
| SCHEMBL3210834 | 0.90 | PIM1 (1.00) | PIM1PIM3PIM2GSK3BPRKCQ | |
| SCHEMBL3210683 | 0.90 | PIM1 (1.00) | PIM1PIM3PIM2GSK3BPRKCQ | |
| SCHEMBL3219071 | 0.90 | PIM1 (1.00) | PIM1PIM3PIM2GSK3BPRKCQ | |
| SCHEMBL3263863 | 0.90 | PIM1 (1.00) | PIM1PIM3PIM2GSK3BPRKCQ | |
| SCHEMBL13458121 | 0.89 | PIM1 (0.82) | PIM1PIM3PIM2 | |
| SCHEMBL13458371 | 0.88 | PIM1 (0.67) | PIM1PIM3PIM2 | |
| SCHEMBL13458105 | 0.87 | PIM1 (0.77) | PIM1PIM3PIM2GSK3BPRKCQ | |
| SCHEMBL16982480 | 0.86 | PIM1 (0.90) | PIM1PIM3PIM2GSK3BPRKCQ |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2344474-B1 | PICOLINAMIDE DERIVATIVES AS KINASE INHIBITORS | NOVARTIS AG (CH) | 2015-09-23 | — | — | EP | disclosed |
| WO-2010026124-A1 | PICOLINAMIDE DERIVATIVES AS KINASE INHIBITORS | NOVARTIS AG (CH) | 2010-03-11 | — | — | WO | disclosed |